Biotech bil­lion­aire backs a food al­ler­gy/nu­tri­tion start­up; Ed­i­tas re­cruits a CMO

Swiss biotech bil­lion­aire Ernesto Bertarel­li is putting some of his cash in­to a new Sil­i­con Val­ley start­up that will look to help pre­vent food al­ler­gies be­fore they can take hold. His Gur­net Point Cap­i­tal is tak­ing the lead on a $13 mil­lion Se­ries A for Be­fore Brands.

Cam­bridge, MA-based Ed­i­tas has re­cruit­ed Ger­ald Cox as its new CMO. He was most re­cent­ly VP of Rare Dis­ease Clin­i­cal De­vel­op­ment at Sanofi Gen­zyme and has spent more than 20 years as a prac­tic­ing clin­i­cal ge­neti­cist at Boston Chil­dren’s Hos­pi­tal.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.